Article Details

U.S. FDA Approves TECVAYLI (teclistamab-cqyv), the First Bispecific T-cell Engager ...

Retrieved on: 2022-10-26 08:36:02

Tags for this article:

Click the tags to see associated articles and topics

U.S. FDA Approves TECVAYLI (teclistamab-cqyv), the First Bispecific T-cell Engager .... View article details on hiswai:

Excerpt

... the First Bispecific T-cell Engager Antibody for the Treatment of ... immunomodulatory drug and anti-CD38 monoclonal antibody.1 TECVAYLI™ is a ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up